Navitas Semiconductor Corporation (NVTS)

Inozyme Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-124.49	-84.6	-145.43	73.91	-152.69	-19.04
Depreciation & Amortization	22.04	21.89	20.98	7.84	0.76	0.51
Other Amortization	-	-	-	0.02	0.01	0.01
Loss (Gain) From Sale of Assets	0.16	0.15	-	-	-	-
Asset Writedown & Restructuring Costs	2.01	2.01	-	-	-	-
Loss (Gain) From Sale of Investments	-3.91	-3.91	-	-	-	-
Stock-Based Compensation	22.45	43.03	54.03	63.29	41.4	1.03
Provision & Write-off of Bad Debts	8.44	7.69	-	-	-	-
Other Operating Activities	10.05	-43.24	31.85	-192.24	83.63	0.06
Change in Accounts Receivable	1.76	4.19	-16.73	1.25	-4.11	-3.45
Change in Inventory	10.04	6.76	-3.17	-4.75	-8.57	-2.71
Change in Accounts Payable	8.3	-2.8	13.68	7.14	0.36	3.55
Change in Unearned Revenue	-	-	-	0.46	0.03	-0.29
Change in Other Net Operating Assets	-6.03	-10	3.42	-1.42	-2.52	-0.29
Operating Cash Flow	-48.68	-58.82	-41.38	-44.5	-41.7	-20.63
Capital Expenditures	-1.85	-6.77	-4.78	-4.64	-2.75	-0.22
Cash Acquisitions	-	-	-	-96.36	-	-
Investment in Securities	-	-2.5	-1	-6.7	-0.72	-
Other Investing Activities	-	-	-	0.1	0.01	0.01
Investing Cash Flow	-1.81	-9.27	-5.78	-107.61	-3.47	-0.22
Long-Term Debt Issued	-	-	-	-	2	6
Long-Term Debt Repaid	-	-	-	-6.93	-1.07	-4.8
Net Debt Issued (Repaid)	-0.05	-	-	-6.93	0.93	1.2
Issuance of Common Stock	103.13	3.5	90.15	1.71	0.52	0.03
Repurchase of Common Stock	-	-	-	-0.55	-	-
Other Financing Activities	-3.25	-	-0.48	-0.04	273.1	-0.73
Financing Cash Flow	99.83	3.5	89.66	-5.81	274.55	53.59
Foreign Exchange Rate Adjustments	-	-	-	-	-	0
Net Cash Flow	49.35	-64.6	42.5	-157.92	229.38	32.75
Free Cash Flow	-50.53	-65.59	-46.16	-49.14	-44.45	-20.85
Free Cash Flow Margin	-74.13%	-78.74%	-58.10%	-129.51%	-187.26%	-175.95%
Free Cash Flow Per Share	-0.27	-0.36	-0.27	-0.34	-1.14	-1.28
Cash Interest Paid	0.01	-	-	0.29	0.27	0.22
Cash Income Tax Paid	0.37	0.3	0.16	0.19	0.03	0
Levered Free Cash Flow	33.04	16.1	47.88	56.24	24.87	-12.93
Unlevered Free Cash Flow	33.09	16.19	47.88	56.22	25.02	-12.79
Change in Working Capital	14.07	-1.86	-2.8	2.68	-14.82	-3.19

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q